Glenn Larsen
Directeur/Membre du Conseil chez ANIKA THERAPEUTICS, INC.
Fortune : 777 785 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Cheryl Blanchard | M | 59 | 6 ans | |
| John Henneman | M | 62 | 4 ans | |
| Russell Herndon | M | 65 |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 18 ans |
| Jeffery Thompson | M | 58 | 13 ans | |
| Susan Vogt | F | 70 | 6 ans | |
| Ben Wolozin | M | - |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 10 ans |
| Mark Namaroff | M | 60 | - | |
| Gary Fischetti | M | 63 | 1 ans | |
| Stephen Richard | M | 61 | 4 ans | |
| Sheryl Conley | F | 63 | 3 ans | |
| Mira Leiwant | F | - | 5 ans | |
| David Colleran | M | 52 | 4 ans | |
| Lisa Funiciello | F | - | 2 ans | |
| Jonathan Lanfear | M | 55 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Ian McLeod | M | - | 3 ans | |
| Duane Burnett | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Bob Carpenter | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| James Chase | M | - | 6 ans | |
| Charles Kunsch | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 7 ans |
| Steven Ek | M | - | 4 ans | |
| Anne Nunes | F | 55 | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Sylvia Cheung | F | 50 | 15 ans | |
| Charles Sherwood | M | 76 | 20 ans | |
| Thomas Joseph Burke | M | - |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 11 ans |
| Joseph G. Darling | M | 66 | 3 ans | |
| Joseph Bower | M | 85 | 28 ans | |
| Pieter Muntendam | M | 65 |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | - |
| Garen Bohlin | M | 76 |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | 4 ans |
| Steven J. Chartier | M | 55 | 1 ans | |
| John C. Moran | M | 71 | 9 ans | |
| Steven E. Wheeler | M | 77 | 26 ans | |
| Raymond J. Land | M | 79 | 16 ans | |
| Michael Levitz | M | 50 | 4 ans | |
| Dana M. Alexander | M | 47 | 2 ans | |
| Robert Richard | M | - | 1 ans | |
| Charles Sherwood | M | - | - | |
| Alexei Goraltchouk | M | - | 3 ans | |
| Thomas Finnerty | M | 66 | - | |
| Ellen MacKenzie | F | - | - | |
| Jean Bjerke | F | - | 1 ans | |
| Edward S. Ahn | M | 51 | 5 ans | |
| Christopher Ranjitkar | M | - | 1 ans | |
| Stephen R. Mascioli | M | 69 | 1 ans | |
| Stephen Garbacz | M | 65 | 2 ans | |
| Neil J. Hayward | M | - |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 7 ans |
| Richard Hague | M | 63 | 4 ans | |
| Francesco J. Luppino | M | 55 | 2 ans | |
| Kurt Graves | M | 56 |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | 2 ans |
| Edward Gaj | M | 67 | 4 ans | |
| James Loerop | M | 60 | 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 50 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Glenn Larsen
- Réseau Personnel
